AMCX does have current analyst coverage, but it does not support a clean consensus target far enough above the price to anchor this analysis. According to S&P Global data compiled by StockAnalysis, 8 analysts carry an average one-year price target of about $9.67, implying roughly 8.8% upside from $8.90 — below the 10% threshold needed to make a "can it reach" question meaningful. The published range is tight: a low near $9.00 and a high near $11.00.
Individual verified targets include Morgan Stanley at $9 (Sell, maintained October 2026), J.P. Morgan at $9 (Sell), TD Cowen at $9 (Hold), UBS at $10 (Sell), and Wells Fargo at $11 (Equal Weight). Because the overall average falls short of the 10% test, the $10 figure used here is best understood as a fallback objective from public discussion — a round-number psychological level that sits near the top of the published target range — not an official consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AMCX last closed near $8.90, with a 52-week range of roughly $6.47 to $12.93 and a market capitalization of roughly $355–370 million. Reaching $10 would require an advance of about 12.4%, a modest move that is within the stock's normal weekly volatility.
The path would most likely require two things to hold at once: continued stabilization in streaming revenue and advertising trends, and the market granting the shares a modestly higher valuation multiple. AMCX trades at a depressed valuation relative to revenue, but with trailing twelve-month EPS (earnings per share) negative, traditional earnings-based valuation metrics such as P/E (price-to-earnings ratio) are not meaningful guides today.
Several verified factors could help. The company has been aggressively refinancing debt, redeeming higher-coupon notes and extending maturities, which reduces financial risk. Recent quarters have shown double-digit streaming revenue growth and improving advertising trends, even as total revenue still declines year over year. A debt-lightened balance sheet plus any sign that revenue declines are narrowing could support a re-rating toward the low end of the analyst range, which sits at $9 to $11.
The obstacles are substantial. Cord-cutting continues to shrink the traditional pay-TV base that underpins AMCX's flagship networks, including AMC, BBC America, IFC, and SundanceTV. Revenue has been declining, and the most recent quarter reported non-GAAP (non-standard) EPS of $0.44 alongside a revenue miss, underscoring execution risk. Analysts remain broadly cautious, and the tight target range suggests limited conviction that a sustained re-rating is warranted. Any revenue or margin disappointment could keep the shares anchored near or below current levels.
The stock's 52-week range of approximately $6.47 to $12.93 defines the broader structure. The $10 mark is a natural psychological resistance level that also aligns with the top of the mainstream analyst range, while $9 and $11 represent nearby published reference points. Below the current price, recent trading lows near the $8.40 area have provided some short-term support.
Published analyst targets generally reflect a roughly 12-month horizon, though individual firms differ. Investors weighing the $10 objective should monitor quarterly earnings and guidance for signs that revenue declines are stabilizing, streaming subscriber trends, advertising momentum, and any further debt-reduction or refinancing steps. Analyst revisions will also matter: with a narrow $9–$11 range, even modest target changes can shift sentiment. From what I see, this is important because small shifts in guidance can influence sentiment quickly.
In my own research, Tickeron’s AI Daily Buy/Sell Signals have proven useful for monitoring names like AMCX. The tool applies artificial intelligence to track thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market conditions. It helps me spot potential shifts more efficiently when reviewing volatile stocks, especially alongside earnings and debt updates.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for AMCX crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for AMCX entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMCX's RSI Oscillator exited the oversold zone, 34 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 55 cases where AMCX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for AMCX just turned positive on November 05, 2026. Looking at past instances where AMCX's MACD turned positive, the stock continued to rise in 32 of 41 cases over the following month. The odds of a continued upward trend are 78%.
Following a +5.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMCX advanced for three days, in 203 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
AMCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.380) is normal, around the industry mean (12.833). P/E Ratio (-18.644) is within average values for comparable stocks, (39.433). Projected Growth (PEG Ratio) (0.545) is also within normal values, averaging (2.376). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.271) is also within normal values, averaging (2.932).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. AMCX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMCX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of cable television networks through its subsidiaries
Industry MoviesEntertainment